Insights

  • Date

  • Content Type

  • Reset

Blog

Happily ever after: Why scientific due diligence is key to a successful M&A marriage

23.02.22

By Dr. Diane Seimetz

Why scientific due diligence is key to a successful M&A

Read More

Blog

Extracellular vesicles in drug delivery – Understanding their potential and challenges

11.02.22

By Jörg Schneider

The field of extracellular vesicles is a nascent and rapidly..

Read More

Blog

Accelerating development through manufacturing best practices

17.01.22

By Kate Coleman, MSc.

The journey to commercialization can be fraught with challenges for organizations...

Read More

Blog

The Promise of Converging Disruptive Technologies in Advanced Therapy Production

11.01.22

By Yasser El-Sherbini

Advanced therapeutic medicinal products (ATMPs), better known as cell and gene therapy (CGT) in the United States...

Read More

Blog

Roadmap to commercialization success: Build agility into drug development plans

29.11.21

By Dr. Diane Seimetz

We know the lifechanging impact that gene, cell and tissue-based therapies..

Read More

Blog

The new economics of innovative therapies: Navigating emerging payment models

11.11.21

By Alberto Rubio

For years, market access strategies for new therapies almost exclusively depended on data supporting efficacy and safety. ..

Read More